Long-term outcomes of drug-eluting versus bare-metal stent implantation in patients with chronic total coronary artery occlusions

Chinese Medical Journal

Volumn 122, Issue 6, 2009, Pages 643-647

  Han, Ya Ling ^a   Zhang, Jian ^a   Li, Yi ^a   Wang, Shou Li ^a   Jing, Quan Min ^a   Yi, Xian Hua ^a   Ma, Ying Yan ^a   Luan, Bo ^a   Wang, Geng ^a   Wang, Bin ^a  

^a SHENYANG NORTHERN HOSPITAL   (China)

Author keywords

Chronic disease; Coronary artery disease; Drug eluting stent; Percutaneous transluminal coronary angioplasty

Indexed keywords

ANTITHROMBOCYTIC AGENT; PACLITAXEL; RAPAMYCIN;

ADULT; ARTICLE; BARE METAL STENT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY RECANALIZATION; DRUG ELUTING STENT; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TREATMENT RESPONSE; AGED; ANGIOCARDIOGRAPHY; FOLLOW UP; METHODOLOGY; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY OCCLUSION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; STENTS; TREATMENT OUTCOME;

EID: 67649786627     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2009.06.010     Document Type: Article

References (25)

1. Sirnes PA, Golf S, Myreng Y, Molstad P, Emanuelsson H, Albertsson P, et al. Stenting in Chronic Coronary Occlusion (SICCO): randomized, controlled trial of adding stent implantation after successful angioplasty. J Am Coll Cardiol 1996; 28: 1444-1451.
2. Rubartelli P, Niccoli L, Verna E, Giachero C, Zimarino M, Fomntanelli A, et al. Stent implantation versus balloon angioplasty in chronic coronary occlusions: results from the GISSOC trial. J Am Coll Cardiol 1998; 32: 90-96.
3. Buller CE, Dzavik V, Carere RG, Mancini GB, Barbeau G, Lazzam C, et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). Circulation 1999; 100: 236-242.
4. Lotan C, Rozenman Y, Hendler A, Turgeman Y, Ayzenberg O, Beyar R, et al. Stents in total occlusion for restenosis prevention: the multicenter randomized STOP study. Eur Heart J 2000; 21: 1960-1966.
5. Höher M, Wöhrle J, Grebe OC, Kochs M, Osterhues HH, Hombach V, et al. A randomized trial of elective stenting after balloon recanalization of chronic total occlusions. J Am Coll Cardiol 1999; 34: 722-729.
6. Suttorp MJ, Mast EG, Plokker HW, Kelder JC, Ernst SM, Bal ET, et al. Primary coronary stenting after successful balloon angioplasty of chronic total occlusions: a single-center experience. Am Heart J 1998; 135: 318-322.
7. Sousa JE, Costa MA, Abizaid AC, Abizaid AC, Rensing BJ, Abizaid AS, et al. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007-2011.
8. Morice MC, Serruys PW, Sousa JE, Fajadet J, Hayashi EB, Pwein M, et al for the RAVEL Study Group. A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-1780.
9. Han YL, Wang SL, Jing QM, Li Y, Zhang J, Ma YY, et al. Percutaneous coronary intervention for chronic total occlusion in 1263 patients: a single-center report. Chin Med J 2006; 119: 1165-1170.
10. Noguchi T, Miyazaki S, Morii I, Daikoku S, Goto Y, Nonogi H. Percutaneous transluminal coronary angioplasty of chronic total occlusions. Determinants of primary success and long-term clinical outcome. Catheter Cardiovasc Interv 2000; 49: 258-264.
11. Suero JA, Marso SP, Jones PG, Laster SB, Huber KC, Giorgi LV, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. J Am Coll Cardiol 2001; 38: 409-414.
12. Warren RJ, Black AJ, Valentine PA, Manolas EG, Hunt D. Coronary angioplasty for chronic total occlusion reduces the need for subsequent coronary bypass surgery. Am Heart J 1990; 120: 270-274.
13. Kishi K, Hiasa Y, Kinoshita M, Kondo N, Fujinaga H, Ohtani R, et al. Efficacy and safety of percutaneous transluminal coronary angioplasty of other coronary arteries in patients with chronic total occlusion of the left anterior descending artery. J Cardiol 1995; 25: 303-308.
14. Gottschall CA, Trindade II, Miler VV. Changes in left ventricular function after coronary recanalization by percutaneous transluminal coronary angioplasty (PTCA). J Invasive Cardiol 1997; 9: 146-153.
15. Chung CM, Nakamura S, Tanaka K, Tanigawa J, Kitano K, Akiyama T, et al. Effect of recanalization of chronic total occlusions on global and regional left ventricular function in Patients with or without previous myocardial infarction. Catheter Cardiovasc Interv 2003; 60: 368-374.
16. Lotan C, Almagor Y, Kuiper K, Suttorp MJ, Wijns W. Sirolimus-eluting stent in chronic total occlusion: the SICTO study. J Interv Cardiol 2006; 19: 307-312.
17. Buellesfeld L, Gerckens U, Mueller R, Schmidt T, Grube E. Polymer-based paclitaxel-eluting stent for treatment of chronic total occlusions of native coronaries: results of a Taxus CTO registry. Catheter Cardiovasc Interv 2005; 66: 173-177.
18. Nakamura S, Muthusamy TS, Bae JH, Cahyadi YH, Udayachalerm W, Tresukosol D. Impact of sirolimus-eluting stents on the outcome of patients with chronic total occlusions: multicenter registry in Asia. J Am Coll Cardiol 2004; 43 suppl 1: 35A.
19. Werner GS, Krack A, Schwarz G, Prochnau D, Betge S, Figulla HR. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol 2004; 44: 2301-2306.
20. Ge L, Lakovou L, Cosgrave J, Chieffo A, Montorfano M, Michev I, et al. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 2005; 26: 1056-1062.
21. Hoye A, Tanabe K, Lemos PA, Aoki J, Saia F, Arampatzis C, et al. Significant reduction in restenosis after the use of sirolimus-eluting stents in the treatment of chronic total occlusions. J Am Coll Cardiol 2004; 43: 1954-1958.
22. Nakamura S, Muthusamy TS, Bae JH, Cahyadi YH, Udayachalerm W, Tresukosol D. Impact of sirolimus-eluting stent on the outcome of patients with chronic total occlusions. Am J Cardiol 2005; 95: 161-166.
23. Suttorp MJ, Laarman GJ, Rahel BM, Kelder JC, Bosschaert MA, Kiemeneij F, et al. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II). A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 2006; 114: 921-928.
24. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, et al. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007; 356: 998-1008.
25. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur Heart J 2005; 26: 804-847.